The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): An international internet‐based survey of 1179 MPD patients
Abstract
BACKGROUND.: Few objective data exist on the burden of fatigue and other constitutional symptoms in patients with myeloproliferative disorders (MPD). METHODS.: The authors used validated instruments of fatigue and physical activity assessment during an Internet‐based symptom survey of 1179 MPD patients (median age, 56 years; 41.4% men). RESULTS.: The frequency of self‐reporting was 80.7% for fatigue, which was substantially higher than that of pruritus (52.2%), night sweats (49.2%), bone pain (43.9%), fever (13.7%), and weight loss (13.1%). In the majority of patients, these symptoms restricted participation in both social functions and physical activity. In addition, 34.5% of patients needed assistance with activities of daily living, and 11.2% reported MPD‐associated medical disability. As expected, the presence of myelofibrosis, anemia, splenomegaly, or other features associated with advanced disease favored a higher degree of fatigue. However, fatigue remained the major complaint also in polycythemia vera (84.9%) and essential thrombocythemia (72.4%); these figures were significantly higher than those of published controls (P < .0001). CONCLUSIONS.: The current study identifies fatigue as the major contributor to poor quality of life in MPD, provides baseline information on constitutional symptoms, and underscores the need for the incorporation of quality of life assessment in clinical trials. Cancer 2007. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
A simple method to assess exercise behavior in the community.
Godin, G., & Shephard, R. J. (1985) · PubMed · Cited by 3,824
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Self-citationAlzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
Editorial: Some Speculations on the Myeloproliferative Syndromes
DAMESHEK, W. (1951) · Blood · doi:10.1182/blood.v6.4.372.372 · Cited by 1,082
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera
Landolfi, R., Marchioli, R., Kutti, J., Gisslinger, H., Tognoni, G., Patrono, C., & Barbui, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035572 · Cited by 1,012
Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia
Harrison, C. N., Campbell, P. J., Buck, G., Wheatley, K., East, C. L., Bareford, D., Wilkins, B. S., van der Walt, J. D., Reilly, J. T., Grigg, A. P., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043800 · Cited by 927
Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis
Cortelazzo, S., Finazzi, G., Ruggeri, M., Vestri, O., Galli, M., Rodeghiero, F., & Barbui, T. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321704 · Cited by 843
Myelofibrosis with Myeloid Metaplasia
Tefferi, A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421706 · Cited by 740
Self-citationCella, D. F. (1997) · PubMed · Cited by 687
Review of Exercise Intervention Studies in Cancer Patients
Galvão, D. A., & Newton, R. U. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.085 · Cited by 578
Assessment and management of cancer-related fatigue in adults
Ahlberg, K., Ekman, T., Gaston-Johansson, F., & Mock, V. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14186-4 · Cited by 546
Fatigue and the cancer experience: the state of the knowledge.
Winningham, M. L., Nail, L. M., Burke, M., Brophy, L., Cimprich, B., Jones, L. S., Pickard-Holley, S., Rhodes, V. A., Pierre, B. S., & Beck, S. L. (1994) · PubMed · Cited by 522
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk, P. D., Goldberg, J. D., Donovan, P. B., Fruchtman, S. M., Berlin, N. I., & Wasserman, L. R. (1986) · PubMed · Cited by 493
Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
Elliott, M. A., & Tefferi, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05277.x · Cited by 473
Self-citationInflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors
Collado-Hidalgo, A., Bower, J. E., Ganz, P. A., Cole, S. W., & Irwin, M. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2398 · Cited by 394
Mesa, R. A., Silverstein, M. N., Jacobsen, S. J., Wollan, P. C., & Tefferi, A. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199905)61:1<10::aid-ajh3>3.0.co;2-i · Cited by 354
Self-citationWolanskyj, A. P., Schwager, S. M., McClure, R. F., Larson, D. R., & Tefferi, A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.2.159 · Cited by 329
Self-citationMesa, R. A., Steensma, D. P., Pardanani, A., Li, C.-Y., Elliott, M., Kaufmann, S. H., Wiseman, G., Gray, L. A., Schroeder, G., Reeder, T., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2928 · Cited by 283
Self-citationAllogeneic hematopoietic stem cell transplantation for myelofibrosis
Deeg, H. J., Gooley, T. A., Flowers, M. E. D., Sale, G. E., Slattery, J. T., Anasetti, C., Chauncey, T. R., Doney, K., Georges, G. E., Kiem, H., et al. (2003) · Blood · doi:10.1182/blood-2003-06-1856 · Cited by 258
Effects of fatigue on physical activity and function in patients with Parkinson’s disease
Garber, C. E., & Friedman, J. H. (2003) · Neurology · doi:10.1212/01.wnl.0000055868.06222.ab · Cited by 232
The clinical phenotype of wild‐type, heterozygous, and homozygous JAK2V617F in polycythemia vera
Tefferi, A., Lasho, T. L., Schwager, S. M., Strand, J. S., Elliott, M., Mesa, R., Li, C., Wadleigh, M., Lee, S. J., & Gilliland, D. G. (2006) · Cancer · doi:10.1002/cncr.21645 · Cited by 221
Self-citationWinningham, M. L., MacVicar, M. G., Bondoc, M., Anderson, J. I., & Jp, M. (1989) · PubMed · Cited by 205
Cella, D., Zagari, M. J., Vandoros, C., Gagnon, D. D., Hurtz, H.-J., & Nortier, J. W. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.136 · Cited by 204
Wang, X. S., Giralt, S., Mendoza, T. R., Engstrom, M. C., Johnson, B. A., Peterson, N., Broemeling, L. D., & Cleeland, C. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1319 · Cited by 129
Hayes, S. C., Davies, P. S. W., Parker, A. W., Bashford, J., & Newman, B. M. (2004) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704378 · Cited by 83
Quality‐of‐life and health benefits of early treatment of mild anemia
Straus, D. J., Testa, M. A., Sarokhan, B. J., Czuczman, M. S., Tulpule, A., Turner, R. R., & Riggs, S. A. (2006) · Cancer · doi:10.1002/cncr.22221 · Cited by 67
The rapid assessment of fatigue severity in cancer patients
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990301)85:5 · Cited by 1
Cited by
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Verstovsek, S., Kantarjian, H., Mesa, R. A., Pardanani, A. D., Cortes-Franco, J., Thomas, D. A., Estrov, Z., Fridman, J. S., Bradley, E. C., Erickson-Viitanen, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002028 · Cited by 1,164
Self-citationEmanuel, R. M., Dueck, A. C., Geyer, H. L., Kiladjian, J.-J., Slot, S., Zweegman, S., te Boekhorst, P. A. W., Commandeur, S., Schouten, H. C., Sackmann, F., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.3863 · Cited by 457
Self-citationSingal, A. K., Kamath, P. S., & Tefferi, A. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.012 · Cited by 389
Self-citationTefferi, A., Cervantes, F., Mesa, R., Passamonti, F., Verstovsek, S., Vannucchi, A. M., Gotlib, J., Dupriez, B., Pardanani, A., Harrison, C., et al. (2013) · Blood · doi:10.1182/blood-2013-03-488098 · Cited by 386
Self-citationScherber, R., Dueck, A. C., Johansson, P., Barbui, T., Barosi, G., Vannucchi, A. M., Passamonti, F., Andreasson, B., Ferarri, M. L., Rambaldi, A., et al. (2011) · Blood · doi:10.1182/blood-2011-01-328955 · Cited by 340
Self-citation
Metadata
- Authors
- Mesa, R. A., Niblack, J., Wadleigh, M., Verstovsek, S., Camoriano, J., Barnes, S., Tan, A. D., Atherton, P. J., Sloan, J. A., & Tefferi, A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-12-11
- Volume
- 109
- Issue
- 1
- Pages
- 68-76
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1545484310
- Cited by
- 399
- References
- 28
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.